19 June 2013
Keywords: tibotec, prezista, cleared, hiv, eu, irish, drugmaker
Article | 26 February 2007
Irish drugmaker Tibotec Pharmaceuticals' Prezista (darunavir) has been approved in the European Union for the treatment of HIV. The firm,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 2007
19 February 2007
5 March 2007
© 2013 thepharmaletter.com